José A. Halperin
Brigham and Women's Hospital · 146 works · 5,678 citations · h-index 41
Top works
- Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.
- Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G
- Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells.
- Clotrimazole inhibits cell proliferation in vitro and in vivo
- Membrane signaling by complement C5b-9, the membrane attack complex
- Depletion of intracellular Ca 2+ stores, phosphorylation of eIF2α, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole
- Molecular basis for a link between complement and the vascular complications of diabetes
- Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells.
- Ultrahigh-Resolution 1 H− 13 C HSQC Spectra of Metabolite Mixtures Using Nonlinear Sampling and Forward Maximum Entropy Reconstruction
- Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation
- Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
- Glycation Inactivation of the Complement Regulatory Protein CD59
- Synthesis and Conformational Analysis of a Cyclic Peptide Obtained via i to i+4 Intramolecular Side-Chain to Side-Chain Azide−Alkyne 1,3-Dipolar Cycloaddition
- Paroxysmal Nocturnal Hemoglobinuria
- Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid.
- 3,3-Diaryl-1,3-dihydroindol-2-ones as Antiproliferatives Mediated by Translation Initiation Inhibition
- Voltage-activated cation transport in human erythrocytes
- Complement-mediated neurotoxicity is regulated by homologous restriction
- Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target
- Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation